Jupiter Neurosciences, Inc. (JUNS) stock
JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.52+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.17MP/E –Yield –
Jupiter Neurosciences pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Jupiter Neurosciences
Jupiter Neurosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?